EMEA-001155-PIP01-11-M03 - paediatric investigation plan

Heterologous human adult liver-derived progenitor cells
PIPHuman

Key facts

Active Substance
Heterologous human adult liver-derived progenitor cells
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0115/2016
PIP number
EMEA-001155-PIP01-11-M03
Pharmaceutical form(s)
Cell suspension for infusion
Condition(s) / indication(s)
Treatment of urea cycle disorders
Route(s) of administration
Intravenous use
Contact for public enquiries

Promethera Biosciences

Belgium
Tel. +32 10394300
Fax +32 10394301
E-mail: contact@promethera.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page